103p2d6: tissue specific protein highly expressed in various cancers

Details for Australian Patent Application No. 2001241742 (hide)

Owner Agensys, Inc.

Inventors Mitchell, Steve Chappell; Faris, Mary; Challita-Eid, Pia M.; Afar, Daniel E. H.; Rastegar, Gazelle Shiva; Jakobovits, Aya; Hubert, Rene S.; Raitano, Arthur B.

Agent FB Rice

Pub. Number AU-B-2001241742

PCT Pub. Number WO01/62925

Priority 60218856 13.07.00 US; 60184558 24.02.00 US

Filing date 26 February 2001

Wipo publication date 3 September 2001

Acceptance publication date 6 April 2006

International Classifications

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

22 January 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

19 February 2004 Section 223 Application Allowed

  Agensys, Inc. The time in which to request examination has been extended to 04 Feb 2004. Address for service in Australia - FB Rice & Co 139 Rathdowne Street CARLTON VIC 3053

6 April 2006 Application Accepted

  Published as AU-B-2001241742

11 May 2006 Corrigenda

  Applications Accepted - Name Index Under the name Agensys, Inc., Application No. 2001241742, under INID (54) correct the title to read 103P2D6: tissue specific protein highly expressed in various cancers.

3 August 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001241743-Method for transdermal or intradermal delivery of molecules

2001241741